Reports

The objective of this desk review is to evaluate Puerto Rico's documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds as reported in GrantSolutions and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through June 30, 2021.

The Families First Coronavirus Response Act was signed into law and included a division coined the Emergency Unemployment Insurance Stabilization Access Act of (EUISSA) 2020. The EUISSA authorizes the Department of Labor (DOL) to transfer emergency administrative grants (grants0 to states’ Unemployment Trust Fund for the amount of $1 billion to administer its Unemployment Insurance (UI) program. DOL to date has provided the $1 billion in grants to states to administer the UI program. This audit will determine if DOL provided adequate oversight of states’ use of emergency administrative grant funds authorized under the EUISSA 2020.

The CARES and Continued Assistance Acts expanded states’ ability to provide unemployment insurance for many workers impacted by the COVID-19 pandemic, including for workers who were not ordinarily eligible for unemployment benefits, non traditional claimants. Our audit will determine if non traditional claimants received Unemployment Insurance benefits as intended under the CARES Act and the Continued Assistance Act. 

Audit of ETA’s Oversight of UI Integrity for CARES Act Programs

The objective of this audit engagement is to determine if DOL ensured states had adequate controls to detect, prevent and recover UI improper payments under the Cares Act, and the Continued Assistance Act.

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020. 

The objective of this desk review is to evaluate the State of Alaska documentation supporting the uses of its Coronavirus Relief Fund proceeds as reported in GrantSolutions, and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period March 1 through December 31, 2020, as reported in cycles 1 through 3 in the GrantSolutions portal.